everyledgerAn index of 679,731 U.S. nonprofits · computed from public IRS filings · current through 2024

Sean Kimerling Testicular Cancer Fo Undation Inc

New York, NY / EIN 16-1683652 / Form 990-EZ / latest filing 2023
Operating record · U.S. dollars
Fiscal yearRevenueExpensesNetReserve mo.Staff %
2012209,266166,10143,16511.966%
2013105,123174,585−69,4626.580%
2014129,164141,873−12,7096.984%
2015116,43250,97765,45534.7
201674,75350,82223,93140.5
201771,49038,69532,79563.4
201843,26148,265−5,00449.6
201940,94654,657−13,71140.8
202018,86945,098−26,22942.4
202122,70320,9541,74992.3
202215,86444,769−28,90535.4
202316,86161,099−44,23817.3

In its most recent public year (2023), this organization spent $44,238 more than it brought in. Its reserves stood at about 17.3 months of spending, up from 11.9 in 2012.

Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings

Get this record as a feed

Sean Kimerling Testicular Cancer Fo Undation Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works